경장영양제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Persistence Market Research has unveiled a comprehensive analysis delving deep into the dynamics of the global Enteral Feeding Formula Market. With a keen focus on pivotal market forces, growth catalysts, hurdles, and burgeoning trends, this report furnishes invaluable insights. It presents a wealth of data and statistics, meticulously charting the trajectory of the Enteral Feeding Formula Market from 2024 through 2033, offering stakeholders a robust foundation for strategic decision-making and informed market navigation.

The global enteral feeding formula market is forecasted to expand at a CAGR of 7.1% and thereby increase from a value of US$7.28 Bn in 2024 to US$13.5 Bn by the end of 2033.

Key Insights:

• Enteral Feeding Formula Market Size (2024 Estimate): US$7.28 Billion
• Projected Market Value (2033 Forecast): US$13.5 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 7.1%

Enteral Feeding Formula Market - Report Scope:

The enteral feeding formula market is driven by increasing incidences of chronic diseases, such as cancer and neurological disorders, which necessitate tube feeding. These formulas provide complete nutrition for patients unable to eat normally, supporting their nutritional needs. Aging populations, particularly in developed regions, contribute to the rising demand for enteral feeding formulas. Technological advancements in formulation and delivery methods enhance the efficacy and tolerability of these formulas, improving patient outcomes. The market benefits from the growing preference for home-based enteral nutrition, driven by healthcare cost containment efforts and patient convenience. The introduction of specialized formulas targeting specific health conditions, such as diabetes and gastrointestinal disorders, further expands market opportunities. Regulatory support and clinical guidelines promoting the use of enteral nutrition contribute to market growth, ensuring patient safety and product efficacy.

Market Growth Drivers:

The enteral feeding formula market is primarily driven by the increasing prevalence of chronic diseases and disorders that require long-term nutritional support. Conditions such as cancer, stroke, and neurological disorders necessitate enteral feeding to meet patients' nutritional needs effectively. Aging populations worldwide are at higher risk of malnutrition, boosting demand for enteral feeding formulas. Technological advancements in tube feeding equipment and formula composition enhance patient comfort and ensure better nutrition absorption, driving market growth. Rising healthcare expenditures, particularly in developed regions, support the adoption of enteral nutrition as a cost-effective solution for managing chronic diseases. The expansion of home healthcare services and the development of patient-centric nutrition plans further promote market growth. Additionally, the development of disease-specific formulas tailored to meet the nutritional needs of patients with specific health conditions presents new growth opportunities in the market.

Market Restraints:

Despite the growth prospects, the enteral feeding formula market faces several challenges, including the high cost associated with specialized formulas and feeding equipment. Limited reimbursement for enteral nutrition products in some regions can restrict market expansion, particularly in developing countries. Concerns regarding the safety and efficacy of enteral feeding formulas may deter patient compliance and adoption. The risk of complications, such as tube-related infections and feeding intolerance, poses challenges for healthcare providers and patients. Issues related to tube placement and maintenance require skilled healthcare professionals, limiting accessibility in certain regions. Regulatory complexities and stringent quality standards for enteral feeding formulas may increase manufacturing costs and delay product launches. Moreover, the ethical considerations surrounding the use of tube feeding in patients with advanced dementia or end-of-life care present ethical dilemmas for healthcare providers and caregivers.

Market Opportunities:

The enteral feeding formula market presents opportunities for growth through the development of innovative formulations and advanced delivery systems. The introduction of disease-specific formulas tailored to meet the nutritional requirements of patients with specific health conditions, such as diabetes and gastrointestinal disorders, offers significant growth potential. The expansion of home enteral nutrition services and the development of patient-centric nutrition plans enhance market penetration. Technological advancements in feeding tube design and material improve patient comfort and reduce the risk of complications, driving market growth. Increasing healthcare expenditures and the rising prevalence of chronic diseases worldwide support market expansion. The integration of digital health technologies and telehealth services in enteral nutrition management enhances patient care and promotes market growth. Partnerships and collaborations between healthcare providers and enteral feeding formula manufacturers facilitate product innovation and market expansion.

Key Questions Addressed in the Report:

• What is the Expected Value CAGR of the Enteral Feeding Formula Market?
• What is the Revenue Size of the Global Enteral Feeding Formula Market as of 2024-end?
• Which Country Held the Largest Market Share in 2024?
• Who are the Key Players in the Global Enteral Feeding Formula Market?
• Which is the Fastest-growing Segment of the Market by Product Type?

Competitive Landscape and Business Strategies:

Prominent organizations like Abbott Laboratories, Nestle Health Science, and Danone Nutricia lead the enteral feeding formula sector. Abbott Laboratories focuses on research and development to innovate and deliver high-quality enteral nutrition products. Expanding its global reach, Abbott collaborates with healthcare providers to improve patient outcomes through advanced nutrition solutions. Nestle Health Science emphasizes personalized nutrition and disease-specific formulas, catering to diverse patient needs. With a robust distribution network, Nestle Health Science ensures market accessibility and product availability. Danone Nutricia leverages its expertise in medical nutrition to develop specialized enteral feeding formulas for critical care and chronic disease management. Danone Nutricia's commitment to scientific research and patient-centric care enhances its market position. These companies prioritize innovation, patient safety, and healthcare provider collaboration, positioning themselves as leaders in the enteral feeding formula market.

Key Companies Profiled:

• Abbott Laboratories
• Nestle Health Science
• Danone Nutricia
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Mead Johnson Nutrition Company
• Hormel Foods Corporation
• Global Health Products, Inc.
• Victus, Inc.
• Medline Industries, Inc.
• Others

Enteral Feeding Formula Market Segmentation:

By Product Type

• Standard Formula
• Disease-specific Formula

By Flow Type

• Intermittent Feeding Flow
• Continuous Feeding Flow

By Stage

• Adult
• Paediatric

By Indication

• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhoea
• Other Indications

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Product Life Cycle Analysis
• 3.5. Supply Chain Analysis
  • 3.5.1. Supply Side Participants and their Roles
    • 3.5.1.1. Producers
    • 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
    • 3.5.1.3. Wholesalers and Distributors
  • 3.5.2. Value Added and Value Created at Node in the Supply Chain
  • 3.5.3. List of Raw Material Suppliers
  • 3.5.4. List of Existing and Potential Buyer's
• 3.6. Investment Feasibility Matrix
• 3.7. Value Chain Analysis
  • 3.7.1. Profit Margin Analysis
  • 3.7.2. Wholesalers and Distributors
  • 3.7.3. Retailers
• 3.8. PESTLE and Porter's Analysis
• 3.9. Regulatory Landscape
  • 3.9.1. By Key Regions
  • 3.9.2. By Key Countries
• 3.10. Regional Parent Market Outlook
• 3.11. Production and Consumption Statistics
• 3.12. Import and Export Statistics

4. Global Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast, 2024-2033

• 4.1. Historical Market Size Value (US$ Bn) & Volume (Tons) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Bn) & Volume (Tons) Projections, 2024-2033
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Bn) & Volume (Tons) Analysis By Product Type, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Bn) & Volume (Tons) Analysis and Forecast By Product Type, 2024-2033
  • 5.3.1. Standard Formula
  • 5.3.2. Disease-specific Formula
• 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2033

6. Global Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Flow Type

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Bn) & Volume (Tons) Analysis By Flow Type, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Bn) & Volume (Tons) Analysis and Forecast By Flow Type, 2024-2033
  • 6.3.1. Intermittent Feeding Flow
  • 6.3.2. Continuous Feeding Flow
• 6.4. Y-o-Y Growth Trend Analysis By Flow Type, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By Flow Type, 2024-2033

7. Global Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Stage

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size Value (US$ Bn) & Volume (Tons) Analysis By Stage, 2019-2023
• 7.3. Current and Future Market Size Value (US$ Bn) & Volume (Tons) Analysis and Forecast By Stage, 2024-2033
  • 7.3.1. Adult
  • 7.3.2. Pediatric
• 7.4. Y-o-Y Growth Trend Analysis By Stage, 2019-2023
• 7.5. Absolute $ Opportunity Analysis By Stage, 2024-2033

8. Global Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size Value (US$ Bn) & Volume (Tons) Analysis By Indication, 2019-2023
• 8.3. Current and Future Market Size Value (US$ Bn) & Volume (Tons) Analysis and Forecast By Indication, 2024-2033
  • 8.3.1. Alzheimer's
  • 8.3.2. Nutrition Deficiency
  • 8.3.3. Cancer Care
  • 8.3.4. Diabetes
  • 8.3.5. Chronic Kidney Diseases
  • 8.3.6. Orphan Diseases
  • 8.3.7. Dysphagia
  • 8.3.8. Pain Management
  • 8.3.9. Malabsorption/GI Disorder/Diarrhea
  • 8.3.10. Other Indications
• 8.4. Y-o-Y Growth Trend Analysis By Indication, 2019-2023
• 8.5. Absolute $ Opportunity Analysis By Indication, 2024-2033

9. Global Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 9.1. Introduction
• 9.2. Historical Market Size Value (US$ Bn) & Volume (Tons) Analysis By Region, 2019-2023
• 9.3. Current Market Size Value (US$ Bn) & Volume (Tons) Analysis and Forecast By Region, 2024-2033
  • 9.3.1. North America
  • 9.3.2. Latin America
  • 9.3.3. Europe
  • 9.3.4. Asia Pacific
  • 9.3.5. Middle East and Africa
• 9.4. Market Attractiveness Analysis By Region

10. North America Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 10.1. Historical Market Size Value (US$ Bn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Bn) & Volume (Tons) Forecast By Market Taxonomy, 2024-2033
  • 10.2.1. By Country
    • 10.2.1.1. U.S.
    • 10.2.1.2. Canada
  • 10.2.2. By Product Type
  • 10.2.3. By Flow Type
  • 10.2.4. By Stage
  • 10.2.5. By Indication
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By Flow Type
  • 10.3.4. By Stage
  • 10.3.5. By Indication
• 10.4. Key Takeaways

11. Latin America Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 11.1. Historical Market Size Value (US$ Bn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Bn) & Volume (Tons) Forecast By Market Taxonomy, 2024-2033
  • 11.2.1. By Country
    • 11.2.1.1. Brazil
    • 11.2.1.2. Mexico
    • 11.2.1.3. Rest of Latin America
  • 11.2.2. By Product Type
  • 11.2.3. By Flow Type
  • 11.2.4. By Stage
  • 11.2.5. By Indication
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Product Type
  • 11.3.3. By Flow Type
  • 11.3.4. By Stage
  • 11.3.5. By Indication
• 11.4. Key Takeaways

12. Europe Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 12.1. Historical Market Size Value (US$ Bn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Bn) & Volume (Tons) Forecast By Market Taxonomy, 2024-2033
  • 12.2.1. By Country
    • 12.2.1.1. Germany
    • 12.2.1.2. U.K.
    • 12.2.1.3. France
    • 12.2.1.4. Spain
    • 12.2.1.5. Italy
    • 12.2.1.6. Russia
    • 12.2.1.7. Rest of Europe
  • 12.2.2. By Product Type
  • 12.2.3. By Flow Type
  • 12.2.4. By Stage
  • 12.2.5. By Indication
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Product Type
  • 12.3.3. By Flow Type
  • 12.3.4. By Stage
  • 12.3.5. By Indication
• 12.4. Key Takeaways

13. Asia Pacific Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 13.1. Historical Market Size Value (US$ Bn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Bn) & Volume (Tons) Forecast By Market Taxonomy, 2024-2033
  • 13.2.1. By Country
    • 13.2.1.1. China
    • 13.2.1.2. Japan
    • 13.2.1.3. India
    • 13.2.1.4. South Korea
    • 13.2.1.5. Australia
    • 13.2.1.6. Rest of APAC
  • 13.2.2. By Product Type
  • 13.2.3. By Flow Type
  • 13.2.4. By Stage
  • 13.2.5. By Indication
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Product Type
  • 13.3.3. By Flow Type
  • 13.3.4. By Stage
  • 13.3.5. By Indication
• 13.4. Key Takeaways

14. Middle East and Africa Enteral Feeding Formulas Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 14.1. Historical Market Size Value (US$ Bn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Bn) & Volume (Tons) Forecast By Market Taxonomy, 2024-2033
  • 14.2.1. By Country
    • 14.2.1.1. South Africa
    • 14.2.1.2. Saudi Arabia
    • 14.2.1.3. UAE
    • 14.2.1.4. Israel
    • 14.2.1.5. Rest of MEA
  • 14.2.2. By Product Type
  • 14.2.3. By Flow Type
  • 14.2.4. By Stage
  • 14.2.5. By Indication
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Product Type
  • 14.3.3. By Flow Type
  • 14.3.4. By Stage
  • 14.3.5. By Indication
• 14.4. Key Takeaways

15. Key Countries Enteral Feeding Formulas Market Analysis

• 15.1. U.S.
  • 15.1.1. Pricing Analysis
  • 15.1.2. Market Share Analysis, 2024
    • 15.1.2.1. By Product Type
    • 15.1.2.2. By Flow Type
    • 15.1.2.3. By Stage
    • 15.1.2.4. By Indication
• 15.2. Canada
  • 15.2.1. Pricing Analysis
  • 15.2.2. Market Share Analysis, 2024
    • 15.2.2.1. By Product Type
    • 15.2.2.2. By Flow Type
    • 15.2.2.3. By Stage
    • 15.2.2.4. By Indication
• 15.3. Brazil
  • 15.3.1. Pricing Analysis
  • 15.3.2. Market Share Analysis, 2024
    • 15.3.2.1. By Product Type
    • 15.3.2.2. By Flow Type
    • 15.3.2.3. By Stage
    • 15.3.2.4. By Indication
• 15.4. Mexico
  • 15.4.1. Pricing Analysis
  • 15.4.2. Market Share Analysis, 2024
    • 15.4.2.1. By Product Type
    • 15.4.2.2. By Flow Type
    • 15.4.2.3. By Stage
    • 15.4.2.4. By Indication
• 15.5. Germany
  • 15.5.1. Pricing Analysis
  • 15.5.2. Market Share Analysis, 2024
    • 15.5.2.1. By Product Type
    • 15.5.2.2. By Flow Type
    • 15.5.2.3. By Stage
    • 15.5.2.4. By Indication
• 15.6. U.K.
  • 15.6.1. Pricing Analysis
  • 15.6.2. Market Share Analysis, 2024
    • 15.6.2.1. By Product Type
    • 15.6.2.2. By Flow Type
    • 15.6.2.3. By Stage
    • 15.6.2.4. By Indication
• 15.7. France
  • 15.7.1. Pricing Analysis
  • 15.7.2. Market Share Analysis, 2024
    • 15.7.2.1. By Product Type
    • 15.7.2.2. By Flow Type
    • 15.7.2.3. By Stage
    • 15.7.2.4. By Indication
• 15.8. Spain
  • 15.8.1. Pricing Analysis
  • 15.8.2. Market Share Analysis, 2024
    • 15.8.2.1. By Product Type
    • 15.8.2.2. By Flow Type
    • 15.8.2.3. By Stage
    • 15.8.2.4. By Indication
• 15.9. Italy
  • 15.9.1. Pricing Analysis
  • 15.9.2. Market Share Analysis, 2024
    • 15.9.2.1. By Product Type
    • 15.9.2.2. By Flow Type
    • 15.9.2.3. By Stage
    • 15.9.2.4. By Indication
• 15.10. Russia
  • 15.10.1. Pricing Analysis
  • 15.10.2. Market Share Analysis, 2024
    • 15.10.2.1. By Product Type
    • 15.10.2.2. By Flow Type
    • 15.10.2.3. By Stage
    • 15.10.2.4. By Indication
• 15.11. China
  • 15.11.1. Pricing Analysis
  • 15.11.2. Market Share Analysis, 2024
    • 15.11.2.1. By Product Type
    • 15.11.2.2. By Flow Type
    • 15.11.2.3. By Stage
    • 15.11.2.4. By Indication
• 15.12. Japan
  • 15.12.1. Pricing Analysis
  • 15.12.2. Market Share Analysis, 2024
    • 15.12.2.1. By Product Type
    • 15.12.2.2. By Flow Type
    • 15.12.2.3. By Stage
    • 15.12.2.4. By Indication
• 15.13. India
  • 15.13.1. Pricing Analysis
  • 15.13.2. Market Share Analysis, 2024
    • 15.13.2.1. By Product Type
    • 15.13.2.2. By Flow Type
    • 15.13.2.3. By Stage
    • 15.13.2.4. By Indication
• 15.14. South Korea
  • 15.14.1. Pricing Analysis
  • 15.14.2. Market Share Analysis, 2024
    • 15.14.2.1. By Product Type
    • 15.14.2.2. By Flow Type
    • 15.14.2.3. By Stage
    • 15.14.2.4. By Indication
• 15.15. Australia
  • 15.15.1. Pricing Analysis
  • 15.15.2. Market Share Analysis, 2024
    • 15.15.2.1. By Product Type
    • 15.15.2.2. By Flow Type
    • 15.15.2.3. By Stage
    • 15.15.2.4. By Indication
• 15.16. South Africa
  • 15.16.1. Pricing Analysis
  • 15.16.2. Market Share Analysis, 2024
    • 15.16.2.1. By Product Type
    • 15.16.2.2. By Flow Type
    • 15.16.2.3. By Stage
    • 15.16.2.4. By Indication
• 15.17. Saudi Arabia
  • 15.17.1. Pricing Analysis
  • 15.17.2. Market Share Analysis, 2024
    • 15.17.2.1. By Product Type
    • 15.17.2.2. By Flow Type
    • 15.17.2.3. By Stage
    • 15.17.2.4. By Indication
• 15.18. UAE
  • 15.18.1. Pricing Analysis
  • 15.18.2. Market Share Analysis, 2024
    • 15.18.2.1. By Product Type
    • 15.18.2.2. By Flow Type
    • 15.18.2.3. By Stage
    • 15.18.2.4. By Indication
• 15.19. Israel
  • 15.19.1. Pricing Analysis
  • 15.19.2. Market Share Analysis, 2024
    • 15.19.2.1. By Product Type
    • 15.19.2.2. By Flow Type
    • 15.19.2.3. By Stage
    • 15.19.2.4. By Indication

16. Market Structure Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Benchmarking
• 16.3. Market Share Analysis of Top Players
  • 16.3.1. By Regional
  • 16.3.2. By Product Type
  • 16.3.3. By Flow Type
  • 16.3.4. By Stage
  • 16.3.5. By Indication

17. Competition Analysis

• 17.1. Competition Deep Dive
  • 17.1.1. Danone
    • 17.1.1.1. Overview
    • 17.1.1.2. Product Portfolio
    • 17.1.1.3. Profitability by Market Segments
    • 17.1.1.4. Sales Footprint
    • 17.1.1.5. Strategy Overview
      • 17.1.1.5.1. Marketing Strategy
      • 17.1.1.5.2. Product Strategy
      • 17.1.1.5.3. Channel Strategy
  • 17.1.2. Nestle Nutrition
    • 17.1.2.1. Overview
    • 17.1.2.2. Product Portfolio
    • 17.1.2.3. Profitability by Market Segments
    • 17.1.2.4. Sales Footprint
    • 17.1.2.5. Strategy Overview
      • 17.1.2.5.1. Marketing Strategy
      • 17.1.2.5.2. Product Strategy
      • 17.1.2.5.3. Channel Strategy
  • 17.1.3. Abbott Nutrition
    • 17.1.3.1. Overview
    • 17.1.3.2. Product Portfolio
    • 17.1.3.3. Profitability by Market Segments
    • 17.1.3.4. Sales Footprint
    • 17.1.3.5. Strategy Overview
      • 17.1.3.5.1. Marketing Strategy
      • 17.1.3.5.2. Product Strategy
      • 17.1.3.5.3. Channel Strategy
  • 17.1.4. Mead Johnson & Company, LLC
    • 17.1.4.1. Overview
    • 17.1.4.2. Product Portfolio
    • 17.1.4.3. Profitability by Market Segments
    • 17.1.4.4. Sales Footprint
    • 17.1.4.5. Strategy Overview
      • 17.1.4.5.1. Marketing Strategy
      • 17.1.4.5.2. Product Strategy
      • 17.1.4.5.3. Channel Strategy
  • 17.1.5. Fresenius Kabi AG
    • 17.1.5.1. Overview
    • 17.1.5.2. Product Portfolio
    • 17.1.5.3. Profitability by Market Segments
    • 17.1.5.4. Sales Footprint
    • 17.1.5.5. Strategy Overview
      • 17.1.5.5.1. Marketing Strategy
      • 17.1.5.5.2. Product Strategy
      • 17.1.5.5.3. Channel Strategy
  • 17.1.6. Meiji Holdings Co., Ltd.
    • 17.1.6.1. Overview
    • 17.1.6.2. Product Portfolio
    • 17.1.6.3. Profitability by Market Segments
    • 17.1.6.4. Sales Footprint
    • 17.1.6.5. Strategy Overview
      • 17.1.6.5.1. Marketing Strategy
      • 17.1.6.5.2. Product Strategy
      • 17.1.6.5.3. Channel Strategy
  • 17.1.7. Victus
    • 17.1.7.1. Overview
    • 17.1.7.2. Product Portfolio
    • 17.1.7.3. Profitability by Market Segments
    • 17.1.7.4. Sales Footprint
    • 17.1.7.5. Strategy Overview
      • 17.1.7.5.1. Marketing Strategy
      • 17.1.7.5.2. Product Strategy
      • 17.1.7.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology